Liberia vs Marshall Islands: Current health expenditure
Liberia
13.0%
in 2023
Marshall Islands
13.4%
in 2023
Liberia rank
6th
Marshall Islands rank
5th
Current health expenditure over time
- Liberia
- Marshall Islands
How they compare
Marshall Islands currently reports 13.4% against 13.0% in Liberia, a difference of 0.4%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Marshall Islands ahead.
Liberia ranks 6th and Marshall Islands ranks 5th of 193 countries.
Across the 3 decades both report, Liberia averaged higher in 1 and Marshall Islands in 2.
Head to head by decade
| Decade | Liberia | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.7% | 16.0% | 11.2% | Marshall Islands |
| 2010s | 8.9% | 13.6% | 4.7% | Marshall Islands |
| 2020s | 13.2% | 12.9% | 0.3% | Liberia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher current health expenditure, Liberia or Marshall Islands?
- Marshall Islands, at 13.4% against 13.0% in Liberia as of 2023.
- What is the difference in current health expenditure between Liberia and Marshall Islands?
- 0.4%, with Marshall Islands ahead.
- How many years of comparable data are there for Liberia and Marshall Islands?
- 24 years are reported by both, from 2000 to 2023.
- How do Liberia and Marshall Islands rank globally for current health expenditure?
- Liberia ranks 6th and Marshall Islands ranks 5th of 193 countries.
- Where does this data come from?
- Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Current health expenditure (% of GDP). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Level of current health expenditure expressed as a percentage of GDP. Estimates of current health expenditures include healthcare goods and services consumed during each year. This indicator does not include capital health expenditures such as buildings, machinery, IT and stocks of vaccines for emergency or outbreaks.